SCI
29January
Surgeryformalignantpleuralmesotheliomaafterradiotherapy(SMART):finalresultsfromasingle-centre,phase2trial
ChoBCJ,DonahoeL,BradburyPA,etal.Surgeryformalignantpleuralmesotheliomaafterradiotherapy(SMART):finalresultsfromasingle-centre,phase2trial.TheLancetOncology.
Correspondingauthor:DrJohnCho,DepartmentofRadiationOncology,PrincessMargaretCancerCentre,UniversityofToronto,Toronto,ONM5G1X6,Canadajohn.cho
rmp.uhn.caBackground背景Anovelapproachformanagingmalignantpleuralmesothelioma,surgeryformesotheliomaafterradiotherapy(SMART),consistingofashortacceleratedcourseofhigh-dose,hemithoracic,intensitymodulatedradiotherapy(IMRT)followedbyextrapleuralpneumonectomywasdeveloped.TheaimofthisstudywastoevaluatetheclinicalfeasibilityoftheSMARTprotocol.
一种恶性胸膜间皮瘤的新治疗方法-放疗后行手术治疗(SMART),即大剂量,半胸腔,强度调控放疗(IMRT)的短期加速疗程后进行胸膜外肺切除术。本研究的目的是评估SMART方案的临床可行性。
Methods方法Inthissingle-centre,phase2trial,patientsaged18yearsorolderwithanEasternCooperativeOncologyGroupperformancestatusof0–2,withhistologicallyproven,resectable,cT1–3N0M0diseasewhohadpreviouslyuntreatedmalignantpleuralmesotheliomawereeligibleforinclusion.Patientsreceived25Gyinfivedailyfractionsover1weektotheentireipsilateralhemithoraxwithacon